Send the following on WhatsApp
Continue to ChatBiocon drug receives DCGI nod for use in moderate to severe COVID-19 patients - The Indian Express https://www.indiafinancenews.com/biocon-drug-receives-dcgi-nod-for-use-in-moderate-to-severe-covid-19-patients-the-indian-express/